Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients: A Single Center Experience With Oral Ganciclovir Versus Valganciclovir

NCT00364052 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT00364052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00364052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients: A Single Center Experience With Oral Ganciclovir Versus Valganciclovir
Lead sponsor
Oregon Health and Science University
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2006
Completion date
January 31, 2007
Enrollment
200
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplantation